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Abstract 
Smoking is the single most important risk factor in the development of postoperative 
complications.  Daily smoking increases the risk of postoperative complications by a factor of 
two to four.  Smoking cessation preoperatively is beneficial in increasing rates of cessation and 
therefore reducing the incidence of complications postoperatively.  As a result, smoking 
cessation should be recognized as a core element of care for the preoperative management of the 
surgical patient.  Although the benefits of smoking cessation are well established, as is 
substantial evidence demonstrating that brief interventions are effective in increasing cessation 
rates among users, clinicians fail to consistently address the issue of tobacco use or provide 
smoking cessation interventions.  Referral to elective surgical procedures provides an excellent 
opportunity for primary providers to promote smoking cessation interventions. 
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Preoperative Smoking Cessation Intervention: A Critical Appraisal of the Evidence with Practice 
Recommendations 
In the United States, 53.3 million surgical and non-surgical procedures are performed 
annually with eight to ten million procedures being performed on cigarette smokers (Mills et al., 
2011).  Smokers who undergo surgery have a higher incidence of postoperative complications 
then nonsmokers and are a greater burden on health care resources (Gourgiotis et al., 2011; 
Moller & Tonnesen, 2006; Moller, Villebro, Pedersen, & Tonnesen, 2002; Warner, 2005).   
Smoking is well established as a significant risk factor in the development of postoperative 
complications, particularly those related to impaired wound healing, cardio-pulmonary 
complications, infectious complications, requirement of postoperative intensive care, and 
mortality (Gronkjaer et al., 2014; Moller, Pedersen, Villebro, & Munksgaard, 2003; Schmid et 
al., 2015; Thomsen, Villebro, & Moller, 2014; Turan et al., 2011).  Acquired postoperative 
complications require additional surgical or medical intervention, prolonged hospitalization, 
delays in discharge, and increases in health care costs (Meyers, Hajek, Hinds, & McRobbie, 
2011).  Although the effects of smoking on postoperative outcomes are well documented, the 
recommended duration of smoking cessation to avoid the incidence of these complications vary. 
Smoking cessation preoperatively is beneficial in reducing the incidence of postoperative 
complications and for this reason, it is strongly recommended that all patients be counseled on 
smoking cessation prior to surgery (Mills et al., 2011; Moller et al., 2003; Thomsen et al., 2014; 
Zaman, Mahmood, & Tang, 2012).  Unfortunately, clinicians fail to consistently address the 
issue of tobacco use or provide smoking cessation intervention to patients undergoing elective 
surgery, despite being aware of the significant health threats of tobacco’s use and substantial 
evidence demonstrating that brief interventions are effective in increasing cessation rates among 
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tobacco users (Shannon-Cain, Webster, & Cain, 2002; U.S. Department of Health & Human 
Services [USDHHS], 2008; Wolfenden et al., 2005).  Two million complications could be 
avoided if a smoking cessation intervention were offered to all patients undergoing surgery, 
assuming a 25% rate of cessation (Mills et al., 2011).  
Because of the complications inherent in smoking, cessation should be recognized as a 
core element of care in the preoperative management of the surgical patient (Warner, 2005; 
Wolfenden et al., 2005).  Referral to elective surgical procedures would provide an excellent 
opportunity for primary care providers (PCPs) to promote smoking cessation interventions.  
Counseling on smoking cessation and postoperative outcomes should be initiated at the time of 
the referral to achieve optimal smoking cessation periods (Tonnesen et al., 2010; Warner, 2005).  
Preoperative visits with surgical teams are often too brief or too close to the time of operation to 
ensure this optimal period of cessation is achievable.  
The purpose of this project is to critically appraise the available literature to explore the 
effects of preoperative smoking on the incidence of postoperative complications and to identify 
the value of smoking cessation interventions preoperatively in the adult patient undergoing 
elective surgery.  Findings from this critical appraisal were combined with current guidelines to 
establish a recommended period for cessation and to provide an evidenced-based intervention for 
preoperative smoking cessation.  An understanding of the current information in relation to 
smoking cessation provided valuable insight into appropriate interventions and improved clinical 
practice. The outcomes of this evidence-based study were to:  
 Understand the effects of preoperative smoking on the incidence of postoperative 
complications in patients undergoing elective surgery;  
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 Identify the optimal intervention period of preoperative smoking cessation in 
patients undergoing elective surgery;  
 Identify an effective and easily implemented smoking cessation intervention 
recommendation for primary care providers consistent with current evidence-
based practice guidelines and research recommendations. 
Background and Significance 
Tobacco use remains the single largest most preventable cause of death and disease in the 
United States.  Despite downward trends in smoking prevalence, an estimated 42.1 million, or 
17.8% of U.S. adults are cigarette smokers (Centers for Disease Control and Prevention [CDCP], 
2013).  Smoking places a heavy burden on the individual and on society as a whole.  Cigarette 
smoking causes approximately 480,000 deaths annually, equating to approximately 1,300 deaths 
daily (CDCP, 2013).  In addition, the total economic cost of smoking was more than $300 billion 
in 2013, including nearly $170 billion in direct medical care for adults and $156 billion in lost 
productivity (CDCP, 2013).   
In general, individuals who smoke are less healthy when compared to those who do not, 
are ill more often, seek medical treatment more frequently and have a higher incidence of 
hospital admissions and absenteeism from work (CDCP, 2013).  Beginning at an earlier age and 
in adult life, these individuals suffer health consequences related to smoking (CDCP, 2013).  
Because smokers are more vulnerable to disease, they are at an increased risk of dying from 
otherwise common health events such as pneumonia or complications from routine surgeries 
(Gourgiotis et al., 2011).  Smoke-attributable diseases will continue to cause premature deaths 
and high costs to the nation if the prevalence of use is not reduced.  
Relevance to Alaska 
PREOPERATIVE SMOKING CESSATION                       6 
Compared with the national average of 17.8%, the smoking prevalence in Alaska of 
22.9% exceeds the rates of other states in the nation (CDCP, 2013).  Furthermore, Alaska 
Native/American Indians have the highest prevalence of smoking when compared to other 
racial/ethnic groups making cigarette smoking a major concern to the health of this population 
(CDCP, 2013).  When compared to urban communities, smoking prevalence in both adults and 
adolescents in rural communities is notably higher and has not experienced the same declines 
over the years (American Lung Association, 2012; Hutcheson et al., 2008). 
Literature Review 
Smoking harms nearly every organ in the body.  Even in the absence of smoking-related 
illness, tobacco induced damage to organ systems in combination with surgical trauma result in 
increased risk of postoperative complications (Gourgiotis et al., 2011).  Pathological changes are 
fully or at least partially reversible with preoperative smoking cessation (Gourgiotis et al., 2011).  
Smoking Effects on Body Systems 
The effects of smoking on the respiratory system involve the impairment of ciliary 
function, enhanced mucous production, alterations in immune response (macrophage activity), 
and narrowing of small airways (Gourgiotis et al., 2011; Moller & Tonnesen, 2006; Warner, 
2005).  Cilia are destroyed by the toxins present in cigarette smoke, resulting in impediment of 
mucous clearance.  Poor immobilization of mucous and impaired ciliary function can eventually 
lead to upper and lower respiratory tract infections.  Smoking cessation gradually improves 
pulmonary function, and becomes similar to that of nonsmokers after a cessation period of four 
to eight weeks with longer periods of cessation reducing risk (Nakagawa, Tanaka, Tsukuma, & 
Kishi, 2001; Thomsen et al., 2014; Wong, Lam, Abrishami, Chan, & Chung, 2012).  
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The effects of smoking on the cardiovascular system are short and long-term.  Most 
short-term complications are related to the two main components of cigarette smoke, which 
include carbon monoxide (CO) and nicotine.  CO impairs hemoglobin’s binding capacity to 
oxygen, resulting in a decrease of oxygen content to the tissues and myocardium (Gourgiotis et 
al., 2011; Moller & Tonnesen, 2006; Sorensen, 2012).  Decreases in oxygen result in increased 
erythrocyte production.  This compensation mechanism comes at the expense of increased blood 
viscosity and coagulability (enhancing thrombosis risk) and decreased tissue profusion.  Nicotine 
stimulates the stress responses of the sympathetic nervous system, resulting in increasing heart 
rate, blood pressure, sympathetic tone, and peripheral vasoconstriction.  Long-term 
cardiovascular risks associated with smoking accelerate atherosclerosis and increase risks of 
postoperative myocardial ischemia and infarction (Moller & Tonnesen, 2006; Sorensen, 2012; 
Warner, 2005).   
Of the 7,000 chemicals compounds found in cigarettes, 4,000 can adversely affect wound 
healing (Kuri, Nakagawa, Tanaka, Hasuo, & Kishi, 2005).  Site infections, delayed wound 
healing, dehiscence, hernia, development of fistula and impaired bone healing occur two times 
more often in smokers when compared to nonsmokers; necrosis occurs four times more 
frequently (Sorensen, 2012).  The combination of chemical compounds like nicotine, CO, and 
cyanide compete with the utilization of oxygen and impair enzyme formation necessary in the 
transport and metabolism of oxygen at the cellular level (Kuri et al., 2005; Moller & Tonnesen, 
2006; Warner, 2005).  These substances have been linked as contributing factors for delayed 
wound healing and wound complication.  Significant reductions in surgical site infection and 
impaired wound healing are demonstrated with three to eight weeks of smoking cessation (Kuri 
et al., 2005; Sorensen, 2012; Wong et al., 2012). 
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Smoking Risks Postoperatively 
To answer the first clinical question, literature addressing the issue of postoperative 
smoking complications were reviewed.  Across the spectrum of surgical specialties, the link 
between smoking and postoperative complications is well established.  Smoking is associated 
with an increased risk in the development of postoperative complications.  Impaired wound 
healing, cardio-pulmonary and infectious complications, postoperative intensive care, and 
increased mortality are directly related to preoperative smoking (Gronkjaer et al., 2014; Moller, 
et al., 2003; Schmid et al., 2015; Thomsen et al., 2014; Turan et al., 2011).  
Turan et al. (2011) studied the effects of smoking on surgical outcomes 30 days after 
major surgery in a large retrospective cohort study involving 520,242 non-cardiac surgical 
patients.  Findings indicated that smokers were 1.38 times more likely to die after surgery when 
compared to nonsmokers.  Moreover, smokers experienced significantly greater odds of adverse 
events postoperatively including: higher rates of pneumonia, unplanned intubation, myocardial 
infarction, stroke, superficial and deep incisional infections and sepsis.  
Other researchers report positive correlations between smoking and postoperative 
outcomes.  Gronkjaer et al. (2014) conducted a systematic review and meta analysis of 107 
studies to test the pooled data for statistical significance between preoperative smoking and 
postoperative complications.  In this study, the increased risk of complications was evident in 
patients who smoked compared to nonsmokers.  Smokers were at a significantly higher risk for 
various postoperative complications including: general morbidity, wound complications, general 
infection, pulmonary complications, neurological complications and admission to intensive care 
after an operation.  
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The results of a meta analysis by Schmid and colleagues (2015) are in agreement with 
Gronkjaer et al. (2014).  In this study, Schmid et al., (2015) analyzed the impact of smoking on 
postoperative outcomes in 141,802 patients undergoing one of the sixteen major cardiovascular, 
orthopedic, or oncologic surgical procedures.  Each patient was stratified according to smoking 
status; current smokers had significantly higher odds of developing pulmonary, wound, and 
septic shock complications when compared to nonsmokers.  Retrospectively, the risk of 
developing one complication was 12.5% in nonsmokers, 14.6% in former smokers and 14.9% in 
current smokers.  
Sorensen (2012), conducted a meta analysis and systematic review of cohort studies and 
RCTs to clarify, the effects of smoking on postoperative healing complications and to estimate 
the impact of perioperative smoking cessation interventions on postoperative healing 
complications across surgery specialties.  A total of 140 cohort studies, with 479,150 total 
patients were included in the analysis.  Overall, smokers experienced a significantly increased 
risk of combined postoperative healing complications and wound complications when compared 
to nonsmokers. 
The Impact of Smoking Cessation Interventions on Postoperative Outcomes 
Preoperative smoking cessation is effective in reducing a variety of potential 
postoperative complications with relative postoperative risk for complications varying depending 
on length of cessation.  The exact duration of cessation required to elicit benefit, however is 
inconsistent and likely depends on what outcomes are measured.  Mills et al. (2011) conducted a 
systematic review of all randomized control trials (RCTs), which evaluated the effects of 
smoking cessation on postoperative outcomes, along with all observational studies evaluating 
risk complications in smokers and nonsmokers.  In total, six RCTs and fifteen observational 
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studies were used in this analysis.  The review demonstrated the benefits associated with 
preoperative cessation and postoperative risk reduction.  Relative reductions in pulmonary 
complications were statistically significant among former and current smokers (RR 0.81; 95% 
confidence interval (CI) 0.70-0.93).  Reductions in complications of wound healing were also 
statistically significant among former and current smokers (RR 0.73; 95% CI 0.61-0.87).  RCTs, 
which initiated smoking interventions preoperatively, showed significant decreases in 
postoperative complications, with longer periods of cessation being more effective in reducing 
the incidence of complications.  With each week of cessation, postoperative complications were 
reduced by 19%, affirming that risks steadily decrease as the interval of smoking cessation is 
increased.  Findings from the observational studies examined showed similar results.  
In a RCT, Moller et al. (2002) investigated the effectiveness of a preoperative smoking 
intervention on the frequency of postoperative complications in 120 patients undergoing elective 
hip and knee arthoplasty.  Participants were assigned six to eight weeks preoperatively to either a 
standard care group or a smoking intervention group.  Participants in the smoking intervention 
group were given smoking cessation education, nicotine replacement therapy, and weekly 
counseling sessions with a trained nurse if necessary.  The impact of a smoking cessation 
intervention six to eight weeks in length reduced wound-related complications, and to a lesser 
extent, cardiovascular complications.  The standard care group had an overall risk reduction of 
18% and the intervention group experienced a 52% reduction in risk.  Based on the study 
findings, the authors recommend smoking cessation of at least six weeks preoperatively.  
A large systematic review and meta analysis (Wong et al., 2012) appraised the literature 
of 25 studies to determine the effects of a short-term preoperative smoking cessation on 
postoperative outcomes in 21,381 patients.  When compared with shorter periods of cessation 
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(less than two weeks), longer periods of cessation had a greater effect on the overall reduction of 
postoperative complications.  Smoking cessation gradually improves pulmonary function, and 
becomes similar to that of nonsmokers after cessation periods of four to eight weeks (Nakagawa, 
2001; Thomsen et al., 2014; Wong et al., 2012).  Perioperative smoking cessation for a minimum 
of four weeks reduced respiratory complications by 23% (RR 0.77; 95% CI 0.61-0.96) and was 
further reduced by 47% in patients who had abstained from smoking longer than eight weeks 
before surgery (RR 0.53; 95% CI 0.37-0.76).  Reductions in wound-related complications were 
also noted with cessation periods between three to four weeks (RR 0.69; 95% CI 0.56-0.84).  
A well-known RCT by Sorensen and Jorgensen (2003) sought to determine whether 
short-term preoperative smoking cessation, two to three weeks prior to colorectal surgery 
reduced the incidence of wound complications.  Sixty colorectal surgery patients who smoked 
daily were randomly assigned to either an intervention group (n = 27) or control group (n = 30). 
Members of the intervention group were asked to abstain from smoking at a minimum, the day 
prior to surgery up until the time of suture removal while the control group maintained smoking 
habits.  This study did not demonstrate statistical significance between the intervention (33%) 
and control groups (27%) regarding the incidence of postoperative complications or overall 
postoperative hospital stay.  Although the negative effects of smoking were not found to be 
affected by brief periods of smoking cessation in this study, a longer intervention period may 
have proven to be more beneficial.  Similar results were reflected in a RCT trial in Denmark, 
which examined the effects of a brief smoking cessation in patients undergoing breast cancer 
surgery (Thomsen et al., 2010).  The purpose of this study was to examine if the effects of a short 
term smoking intervention (two to ten days) would influence postoperative complications.  
Complication rates in both groups were 61% (RR 1.0; 95% CI 0.75-1.33).  The study concluded 
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that a brief smoking intervention shortly before breast cancer surgery had no impact on the 
overall rates of postoperative complications.  
Lindstrom et al. (2008) performed a RCT to evaluate the effects of a four week smoking 
intervention on postoperative complications in patients undergoing general and orthopedic 
surgery.  Participants were randomly assigned to an intervention group or control group.  The 
intervention group received individual counseling and nicotine replacement therapy for four 
weeks before surgery and continued four weeks postoperatively.  The control group received 
standard preoperative care.  The study found that abstainers had fewer complications (15%) than 
those who continued to smoke (35%); these results however were not found to be statistically 
significant.  In addition, the study concluded that the motivating effects of surgery may influence 
the success of a smoking cessation intervention and the “…preoperative period might therefore 
represent a golden moment for smoking cessation” (p. 744). 
A Cochrane systematic review (Thomsen et al., 2014) concluded that successful smoking 
cessation interventions initiated at least four weeks before surgery “could potentially reduce 
perioperative complications and lead to long-term health gains if cessation were sustained” 
(Thomsen et al., 2014, p. 5).  RCTs, which enrolled smokers into intervention programs to 
encourage cessation while waiting planned surgery, were reviewed.  In total, 13 studies were 
included in the review.  The authors’ also concluded that brief interventions immediately before 
surgery do not demonstrate reduction in risk postoperatively but may be slightly beneficial in 
modifying smoking behaviors. 
A study conducted in 1989 by Warner et al. raised concerns that smoking cessation 
shortly before surgery was ineffective in reducing postoperative complications and that short 
term smoking cessation actually contributed to overall poorer pulmonary outcomes (Meyers et 
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al., 2011).  This study reported that smokers who stopped smoking closest to their operation date 
or less than eight weeks before surgery, were more likely to experience pulmonary complications 
but the results of this study were not found to be statistically significant.  Although this study 
reported poorer outcomes, the concern for worse outcomes is unfounded and not supported by 
the data; regardless of the anticipated date of surgery, smoking cessation should be encouraged. 
This finding was supported by a systematic review and meta analysis conducted by Meyers et al. 
(2011).  A total of nine observational studies were included in the analysis, which contained 889 
patients.  The results of this review concluded that smoking cessation less than eight weeks does 
not infer increase risks postoperatively and quitting smoking shortly before surgery does not 
increase postoperative complications.  A systematic review of twelve cohort studies by Theadom 
and Cropley (2006), also confirmed that short-term cessation periods do not increase risk. 
Smoking cessation just prior to surgery does not increase the rate of postoperative complications. 
Recommendations from Expert Panels and Advocacy Groups 
Patients referred for elective surgery should be encouraged to stop smoking before the 
operation according to the National Institute for Health and Care Excellence (NICE).  The 
Australian and New Zealand Colleagues (2007), professional statement on smoking cessation 
goes even further to recommend at least six to eight weeks of smoking abstinence during the 
preoperative period.  For optimization of pre- and postoperative care in the adult patient with 
chronic obstructive pulmonary disease (COPD), the same six to eight week period of smoking 
cessation is recommended by the Veteran’s Heath Administration.  Both of these guidelines are 
consistent with a National Guideline Clearinghouse recommendation for risk reduction 
preoperatively, this guideline recommends smoking cessation six weeks before surgery (Strength 
of Evidence = B).  The American College of Surgeons supports smoking cessation counseling 
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during elective surgical consults as well as educational programs to promote effective smoking 
cessation strategies. 
Surgery as a Teachable Moment 
Primary care providers (PCPs) are key players in the delivery of surgical services and 
often facilitate the initial referral to surgery and evaluate patients to ensure medical clearance for 
surgery and anesthesia (Warner, 2005).  Health events, like surgery and disease diagnosis can 
serve as “teachable moments” for smoking cessation.  Teachable moments can motivate a person 
to change behaviors by increasing the perceptions of “risk and negative outcome expectancies 
related to smoking, prompting strong affective or emotional responses” and redefining ones self-
concept and social roles (Shi & Warner, 2010, p. 105).  These key concepts addressing the use of 
tobacco during the preoperative period can improve cessation rates and eventually lead to 
decrease incidence of postoperative outcomes.  
Surgical patients who smoke are not routinely informed of the risks associated with 
continued use of tobacco preoperatively or the benefits of smoking cessation on surgical 
outcomes.  This was demonstrated in a prospective, nonrandomized, non-controlled descriptive 
study by Shannon-Cain et al. (2002), which investigated the information provided to surgical 
patients preoperatively regarding smoking’s effects.  This study’s aim was to determine why 
patients who smoke regularly do not abstain from tobacco use prior to surgery.  Eighty-one 
participants from two major hospitals with a high volume of outpatient procedure were enrolled 
in the study.  A questionnaire, written at a sixth-grade reading level was distributed by a 
registered nurse to all patients in the post anesthesia care unit (PACU) with a history of smoking. 
This study found that patients were not routinely informed of the risks involving tobacco use 
preoperatively or informed of the potential benefits associated with abstinence.  Lack of clarity 
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regarding the effects of smoking cessation on complications as well as concern for worse 
surgical outcomes with recommendations of brief smoking cessation periods were reported as 
reasons for not informing patients.  The study concluded that patients who were informed of the 
overall effects of smoking or specifically the risks of smoking preoperatively were more likely to 
abstain from smoking prior to surgery, resulting in a four- to five-fold increase in smoking 
cessation.  The study also concluded that the perioperative period could be optimal for smoking 
intervention.  
A similar study by Haddock and Burrows (1997), demonstrated comparable results.  The 
study demonstrated an increase in smoking cessation rates when patients were given knowledge 
preoperatively regarding the risks associated with smoking prior to surgical intervention.  Eighty 
percent of the patients in the intervention group and 50% of those in the control group reduced or 
stopped smoking prior to admission.  When patients are provided with knowledge about their 
disease process or treatment, outcomes are typically more favorable.  Although this study was 
done several years ago, positive outcomes were demonstrated for an educational intervention. 
Literature Review Synthesis 
The optimal period of perioperative smoking cessation to promote postoperative benefit 
remains unclear.  Despite differences in the optimal periods of smoking cessation studied in the 
literature, the effect of smoking cessation on postoperative outcomes is evident.  A synthesis of 
the evidence suggest: (a) smokers overall had a higher incidence of complications when 
compared with nonsmokers; (b) active intervention programs to reduce or sustain from smoking 
preoperatively, with each week of cessation increasing the magnitude of effect, are effective in 
reducing postoperative cardio-pulmonary complications and wound-related complications of 
impaired healing and infection (Gronkjaer et al., 2014; Lindstrom, et al., 2008; Mills et al., 2011; 
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Moller, et al., 2002; Schmid et al., 2015; Sorensen & Jorgensen, 2003; Thomsen et al., 2014; 
Tonnesen, et al., 2010; Turan et al., 2011; Wong, 2011; Zaman et al., 2012); (c) the exact 
duration of cessation required to elicit benefit, is inconsistent and likely depends on what 
outcomes are measured and (d) tobacco cessation interventions preoperatively are effective in 
reducing risk.  
Theoretical Framework 
 A significant contribution from behavioral science has been made in the form of social-
psychological models, which aim to explain and predict health behaviors—why individuals take 
or fail to take measures that maintain or protect their health.  One of the most widely accepted 
and well-known approach is the health belief model (HBM).  The HBM was originally 
developed in the 1950s by social psychologists working in the public health service as a way of 
explaining the failure of people to participate in preventative health actions.  It has since 
advanced to include a motivational component.  This model emphasizes that the meaning of 
health varies among individuals.  Health and illness are linked to a person’s individual social or 
cultural position and are shaped by their experience, attitude, knowledge, motivation, values, and 
expectations (Glanz, Rimer, & Viswanath, 2008).  This HBMs core assumptions are based on the 
understanding that individuals will take health-related action if (a) they are susceptible to the 
condition, (b) they feel a negative health outcome can be avoided, (c) there would be serious 
consequences as a result of the condition, and (d) the benefits of taking action outweigh the costs 
(Glanz et al., 2008).  An individual’s readiness to act is defined under six constructs.  These 
include perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cues 
to action, and self-efficacy (Glanz et al., 2008).  
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In the context of this analysis, perceived susceptibility is defined as perceived likelihood 
of developing a postoperative complication.  The belief that pre- and postoperative smoking has 
serious consequences on surgical outcomes is defined as perceived severity in this analysis. 
Perceived benefits are defined as behavior changes related to an individual’s belief regarding 
perceived benefits of cessation.  Self-efficacy is a surgical patient’s confidence that he or she can 
successfully abstain from smoking for the recommended four to eight week period.   
Successful smoking cessation can depend on a variety of factors including; demographic 
characteristics, knowledge regarding the specific disease or condition, and cues to action for the 
engagement of a desired behavior, in other words a recommendation by a provider (Glanz et al., 
2008).  To effectively develop a comprehensive evidence-based intervention, providers must 
have an understanding of basic social and behavioral theories.  The HBM can be valuable in 
enhancing the effectiveness of smoking cessation interventions and addressing individual reasons 
for noncompliance. 
Methodology 
A critical appraisal of the available literature was conducted to ensure that the highest 
level of evidence is utilized for practice change.  The methodical framework for this project will 
follow the progressive, sequential approach of the seven steps of evidence-based practice by 
Melynk and Fineout-Overholt (2005).  This process includes the following steps: Cultivate a 
spirit of inquiry, problem identification, literature search for the best evidence, critical appraisal 
of the evidence, integration of the evidence, evaluation of outcomes and dissemination of results.  
A literature review was conducted utilizing the databases ProQuest, Cumulative Index to 
Nursing and Allied Heath Literature (CINHAL), Cochrane Library, and UpToDate.  Articles 
were also identified through a general search using the University of Alaska Anchorage (UAA)  
PREOPERATIVE SMOKING CESSATION                       18 
“QuickSearch” search engine on the UAA consortium library website.  Database searches 
included the search terms smoking, smoking cessation, smoking cessation intervention, smoking 
cessation program, perioperative tobacco use, tobacco abstinence, perioperative cessation, 
surgery, operation, complications, and postoperative complications.  The search was further 
refined by combining context search terms “OR” & “AND.”  The search terms “smoking 
cessation” AND “postoperative complications”, “preoperative smoking” AND “postoperative 
outcomes” OR surgery, “preoperative smoking cessation intervention” AND “postoperative 
complications”, “preoperative smoking cessation” AND “postoperative complications” were 
used.  Reference lists were also checked to ensure all relevant articles had been identified.  
Articles were then selected for critical appraisal based on their significance to the three 
project topics, whether they were written in the English language, peer-reviewed, whether they 
related to adult human subjects, and those published between 2000 and 2015.  The initial search 
from ProQuest, CINHAL, Cochrane Library and UAA “QuickSearch” combined resulted in 
approximately 1,471 articles.  The title and abstract of each article was reviewed to determine if 
inclusion criteria were met.  Initial evaluation excluded 1,402 articles.  The remaining 69 articles 
were fully read and individually reviewed, paying careful attention to study design, validity of 
findings, and usefulness of results.  Reference lists from those articles as well as identified from 
the online source UpToDate were reviewed in a similar fashion and an additional 13 relevant 
articles were identified.  Of those, 28 articles were selected for cataloging into an evidence-based 
table (EBT) (Appendix A).  Each grid of the EBT contains the following information: American 
Psychological Association (APA) citation, study objectives, level of evidence, research design, 
participants, intervention, outcomes measures, and study limitations.  To determine the overall 
strength of each article included in the EBT, the John Hopkins nursing evidence based practice I-
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V hierarchy of evidence was utilized with level I being the strongest level of evidence and level 
V the weakest.  Systematic reviews of randomized control trials, experimental/randomized 
control trials and meta-analysis of randomized control trials were assigned a level I.  Level II 
evidence was assigned to well-designed quasi-experimental studies.  Level III was assigned to 
non-experimental (cohort/case-controlled/retrospective studies), qualitative, and meta-synthesis 
studies.  Systematic reviews of descriptive studies, qualitative studies and clinical practice 
guidelines were assigned as level IV.  Level V was assigned to evidence from the opinion of 
authorities or reports of expert committees.  Of the total twenty-eight articles selected for 
cataloging into the EBT, thirteen of those articles were of level I evidence, five articles were of 
level II evidence, nine articles were of level III evidence and one article was of level IV 
evidence.   
The most current pertinent guidelines from the United States, Australia & New Zealand, 
and the United Kingdom were reviewed and combined with the results of the literature review.  
The National Guideline Clearing House, Turning Research into Practice (TRIP) Database, BMJ 
Clinical Evidence, and U.S. Preventative Services Task Force were assessed for quality 
recommendations relevant to the topic.  The strength of the evidence supporting the principal 
recommendation was evaluated using the strength of recommendation grading system.  The three 
strength-of-evidence ratings utilized for each principle recommendation was developed by the 
US Department of HHS “Treating Tobacco Use and Dependence: 2008 Update” (Appendix B). 
Discussion 
Given that eight to ten million procedures in the United States are performed on 
individuals who smoke, a small increase in abstinence rates could have a significant effect on 
public health (Shi & Warner, 2010).  The adverse effects of tobacco use on surgical outcomes 
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and on general overall health combined with the potential public health benefits of permanent 
smoking cessation strongly supported the need for improved routine preoperative interventions.  
There are numerous evidence-based strategies that can be employed in the practice setting to 
improve the implementation of a smoking cessation intervention.  Interventions range in 
complexity from brief advice offered by a provider to more intensive behavioral interventions 
with a trained counselor who has extensive knowledge regarding tobacco dependence.  There is 
evidence to suggest that intense smoking cessation interventions are slightly more effective than 
brief interventions with respect to increasing quit rates, more specifically long-term quit rates 
among users (Stead et al., 2013).  The impact of brief smoking cessation interventions on quit 
rates should not be underestimated.  Minimal interventions, which last three or less minutes, 
have been proven to increase abstinence rates (Strength of Evidence = A; USDHHS, 2008).  Not 
only are brief intervention methods effective, the approach is also lucrative, and more applicable 
in the rapid pace of the primary care setting.  
The U.S. Department of HHS (2008), established perhaps the most notable evidenced-
base framework for structuring smoking cessation.  The clinical guideline was created from both 
expert panel opinions and systematic review and meta-analysis of the current literature in 8,700 
articles.  It serves as a critical evidence-based framework to guide the efforts of reducing 
smoking by identifying all smokers and offering quit support.  The approach to smoking 
cessation is widely accepted and adopted in guidelines from the World Health Organization 
(WHO), CDC, The U.S Preventative Service Task Force (USPSTF) and Veteran’s’ Health 
Administration (VHA), among other government and nonprofit organizations.  The U.S 
Department of HHS guideline is also adopted in modified forms in international guidelines in 
Japan, Australia, New Zealand and the United Kingdom.  
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The national clinical guideline recommends a brief smoking cessation intervention 
commonly known as the 5 As model.  This model is an effective and easily implemented 
smoking cessation intervention method for primary care providers.  The 5 As model can be 
employed in the primary care setting and is designed to utilize three minutes or less of the 
clinician’s direct patient time.  The model is intended for use in patients who are willing to make 
a quit attempt.  The steps of this model include: Ask about the current and past use of tobacco, 
advise the patient to quit, assess willingness to quit, assist in the quit attempt, and arrange for 
future follow up.  A relevant question still exists as to how this information will be presented by 
the primary care provider in order to meet the needs of the individual patient undergoing elective 
surgery.  Using the critical framework as a guide, the intervention can be tailored to the 
individual and upcoming surgical event (Appendix C).  
Ask.  All patients should be asked about current and past tobacco use (Strength of 
Evidence = A; USDHHS, 2008).  “It is essential that clinicians and health care delivery systems 
consistently identify and document tobacco use status and treat every tobacco user seen in the 
health care setting” (USDHHS, 2008, p. 7).  Recommendation: - Tobacco users should be 
systematically identified and their tobacco use status documented at every visit (Strength of 
Evidence = A; USDHHS, 2008).  Screening for current or past tobacco use results in three 
responses: the patient currently uses tobacco, the patient used tobacco in the past (ask about 
length of cessation), or the patient has never used tobacco.  
Advise.  Most smokers report that they are willing or want to quit, but despite the 
intervention programs available, utilization of these resources is low (Shi & Warner, 2010).  
When an intervention program is not utilized, success rates are modest (Shi & Warner, 2010).  
Many smokers will make an attempt to quit on their own but fail to maintain cessation despite 
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the desire to quit completely.  Difficulties in the quitting process will result in, on average, five 
failed attempts before permanent cessation is achieved.  Physician advice to quit has been proven 
to increase quit attempts.  Recommendation: - “All physicians should strongly advise every 
patient who smokes to quit because the evidence shows that physician advice to quit smoking 
increases abstinence rates” (Strength of Evidence = A; USDHHS, 2008, p. 82).  The advice from 
other primary providers such as nurse practitioners and physician assistants has also been proven 
effective (USDHHS, 2008). 
Recommendation: - Every tobacco user should be encouraged to quit in a clear, strong, 
and personalized manner (Strength of Evidence = A; USDHHS, 2008).  Quit advice should be 
offered to all patients regardless of receptivity to interventions or long-term quit goals (Strength 
of Evidence = A; USDHHS, 2008).  In the content of this analysis, quit messages should be 
tailored to take advantage of the unique circumstances of surgery.  Patients should be advised of 
the risks of continued smoking on postoperative outcomes and the benefits of smoking cessation.  
Patients should be advised to abstain from smoking four to eight weeks preoperatively.  Taking 
advantage of surgery as a “teachable moment”, patients should also be advised to consider 
permanently quitting.  
The busy nature of the primary care setting does not always present as an optimal 
environment to conduct such interventions.  Evidence suggests that involvement from all levels 
of the healthcare system is necessary for smoking cessation efforts to be successful (Quraishi, 
Orkin & Roizen, 2006; USDHHS, 2008).  Ideally, interventions should be a collaborative effort 
among other medical staff members, and delivery of information by one individual clinician 
would serve as just one component of the process as a whole.  Recommendation: - “Treatment 
delivered by a variety of clinician types increases abstinence rates.  Therefore, all clinicians 
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should provide smoking cessation interventions” (Strength of Evidence = A; USDHHS, 2008, p. 
87).   
Other providers involved in the surgical process such as anesthesiologists and surgeons 
should seize the opportunity to reinforce smoking cessation messages.  Brief, consistent, positive 
reinforcement of these messages has a powerful effect on smoking behaviors and could 
potentiate long-term cessation beyond the surgical encounter (Azodi et al., 2009; Quraishi et al., 
2006; USDHHS, 2008; Warner, 2005).  Smoking cessation interventions can be delivered by a 
variety of providers with equal effectiveness (Warner, 2008).  Recommendation: - “Treatments 
delivered by multiple types of clinicians are more effective than interventions delivered by a 
single type of clinician.  Therefore, the delivery of interventions by more than one type of 
clinician is encouraged” (Strength of Evidence = C; USDHHS, 2008, p. 87).   
Assess. Every patient who reports using tobacco should be assessed for willingness to 
make a quit attempt.  Recommendation: - “Once a tobacco user is identified and advised to quit, 
the clinician should assess the patient’s willingness to quit at this time” (Strength of Evidence = 
C; USDHHS, 2008, p. 79).  Clinician delivered brief interventions, lasting three or fewer 
minutes, are effective in enhancing motivation and likeliness of future quit attempts even in 
patients unwilling to quit (USDHHS, 2008).  Advice to quit and follow-up at the next clinical 
encounter is recommended for those patients unwilling to make a quit attempt. 
Utilizing the key constructs of the HBM when delivering quit advice can be useful in 
increasing motivation and willingness to make a quit attempt.  If the patient does not believe 
smoking preoperatively has consequences (susceptibility) or is a threat to the development of 
complications postoperatively (severity), there is no stimulus to act.  To effectively change health 
behavior, the patient must believe in both susceptibility and severity (Glanz, Rimer, & 
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Viswanath, 2008).  The patient must also believe that the benefits of taking action are beneficial 
and that the necessary changes can be realistically accomplished (Glanz, Rimer, & Viswanath, 
2008).  The patient’s perceived severity or belief that preoperative smoking has serious 
consequences on surgical outcomes, together with perceived benefits or behavior changes related 
to an individual’s belief regarding perceived benefits of cessation, will predict the likelihood of 
successfully abstaining from smoking for the recommended four to eight week period.   
Assist. Pharmacotherapy is an important element of strategies to aid in the quit attempt, 
the odds of successful cessation almost double with the use of medication (USDHHS, 2008; 
Warner, 2008).  Nicotine can be replaced by using a variety of first line delivery systems, 
including inhalers, gum, lozenges, nasal spray and patches.  All systems are effective in 
promoting cessation and each system has its potential advantages and can be tailored to meet the 
individual needs of the patient.  Medication and counseling in combination have been proven to 
be highly effective in increasing quit rates and enhancing treatment outcomes.  
Recommendation: “The combination of counseling and medication is more effective for smoking 
cessation than either medication or counseling alone.  Therefore, whenever feasible and 
appropriate, both counseling and medication should be provided to patients who are trying to 
quit smoking” (Strength of Evidence = A; USDHHS, 2008, p. 101).   
Arrange. For the patient willing to make a quit attempt, arrange for follow-up.  Success 
of smoking cessation for those willing to quit should be addressed at subsequent clinical visits.  
Preferably, after initiating a smoking cessation intervention, assessment of smoking status should 
occur in one week (USDHHS, 2008).  Recommendation: “…abstinent patients should have their 
success acknowledged, and the clinician should offer to assist the patient with problems 
associated with quitting.  Patients who have relapsed should be assessed to determine whether 
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they are willing to make another quit attempt” (Strength of Evidence = C; USDHHS, 2008, p. 
94).     
In addition to provider advice to quit, patients should routinely be referred to quit lines.  
Quit lines have the potential to reach a large number of smokers and serve as an alternative 
resource to assist patients in the quit process.  Quit lines deliver more intensive counseling by a 
trained specialist and serve as additional support for interventions delivered by providers.  In 
addition, quit lines are highly cost-effective and have proven to enhance quit rates (USDHHD, 
2008). 
Significance to Nursing 
Primary care providers are in a favorable position to assist and play a pivotal role in 
helping support patients in maintaining smoking cessation prior to surgical intervention. 
Providers can improve cessation rates by simply asking patients about their use of tobacco and 
by utilizing a brief intervention for smoking cessation.  Furthermore, smokers who are advised 
by their provider to quit have higher odds of quitting and increased motivation to quit when 
compared to smokers who did not receive such advice.  Prior to surgery, patients should be 
educated on the postoperative risks associated with smoking and the benefits of smoking 
cessation.  For primary care providers to better inform their patients, providers must be aware of 
the associated risks of continued smoking on postoperative outcomes and the current literature 
regarding best practices for smoking cessation intervention.  
Dissemination 
A recommended period for cessation and an evidenced-based intervention for 
preoperative smoking cessation will be submitted as a manuscript to the Journal of Advanced 
Nursing (JAN).  This journal is an international, peer-reviewed journal dedicated to addressing 
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aspects of evidence-based nursing.  As the most cited and read nursing journal in the world, the 
JAN would serve as an ideal avenue to reach a broad spectrum of nurse practitioners in all 
specialties.  An alternative dissemination plan would include a local poster presentation at the 
annual AANP conference. 
Conclusion 
It is well documented in the literature that smoking cessation interventions of four to 
eight weeks’ duration significantly lowers the incidence of postoperative complications.  Patients 
who smoke and are undergoing elective surgical procedures can benefit from smoking cessation 
interventions in the preoperative period.  With such high volume of surgery annually and the 
preoperative period representing a teachable moment, smoking cessation interventions could 
potentially have a substantial effect on tobacco use during the preoperative period and in the long 
term.  Benefit accrues not only in terms of postoperative complications but in general overall 
health. 
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Appendix A 
EBT Preoperative Smoking Cessation 
    
Author Study Objectives Level Design  Participants Intervention Outcome Results Limitation/Comment
s 
     
Azodi, O.S., Lindstrom, D., 
Adami, J., Tonnesen, H., 
Nasell, H., Gilljam, H., & 
Wladis, A. (2009). The efficacy 
of a smoking cessation 
programme in patients 
undergoing elective surgery-a 
randomized clinical trial. 
Anesthesia, 64, 259-265.  
To investigate short-
term and long-term 
efficiency of a 
preoperative smoking 
cessation program 
initiated 4 weeks 
preoperatively and 
lasting 4 weeks 
following surgery. 
1 Randomized 
Control 
Trial 
1117 patients 
randomly 
assigned to 
intervention 
(n=48) and 
control groups 
(n=54). 
Weekly meetings or 
telephone counseling 
with a nurse 
professionally trained in 
smoking cessation 
therapy, phone calls from 
national cessation 
helplines, free nicotine 
replacement therapy. 
Goal=cessation 3 weeks 
prior to surgery and 4 
weeks after surgery. 
Intervention group: 
smoking status and 
consumption recorded 
weekly. Self-administered 
questionnaire about 
smoking habits and 
repeated carbon monoxide 
measurements. Successful 
short-term abstinence= No 
tobacco for 3 weeks prior 
to surgery and 4 weeks 
after and if inhaled carbon 
monoxide 2-3 weeks 
postop was < or equal to 
10ppm. 
20/55 (36%) intervention 
and 1/62 (2%) in control 
were successful in 
remaining abstinent per 
study guideliines.13 months 
later: 48/55 (87%) 
intervention remained 
smoke free and 52/62 (84%) 
of control. Successful 
smoking cessation program 
can be initiated as early as 4 
weeks. 
13 month results did 
not include verified 
measurements of CO, small 
sample size, possible type II 
error. Refusal rates were 
high among users. 
Gourgiotos, S., Aloizos, S., 
Aravosita, P., Mystakelli, C., 
Isaia, E., Gakis, C., & Salemis, 
N. (2011). The effects of 
tobacco smoking on the 
incidence and risk of 
intraoperative and 
postoperative complications in 
adults. The Surgeon, 9, 225-
232. 
Effects of smoking 
cessation on risk of 
intra-and post-
operative 
complications and to 
identify the value of 
preoperative smoking 
cessation. 
3 Meta-
synthesis 
Not reported. None Complications were 
defined as secondary 
disease or a negative 
reaction occurring during, 
or after a surgical 
procedure-respiratory, 
cardiovascular, 
gastrointestinal, wound 
infection, mortality and 
duration of hospital stay. 
Studies that did not 
explore these risks were 
excluded. 
Provider education = 
smoking cessation. 
Possible selection 
bias 
Gronkjaer, M., Eliasen, M., 
Skov-Ettrup, LS., Tolstrup, 
JS., Christiansen, A., 
Mikkelsen, S., Becker, U., & 
Flensborg-Madsen, T. (2014). 
Preoperative smoking status 
and postoperative 
complications: a systematic 
review and meta-analysis. Ann 
Surgery 259(1), 52-71. 
Summarize the 
evidence of an 
association between 
preoperative smoking 
and postoperative 
complications. 
1 Meta-
analysis 
with 
systemic 
review 
107 studies  None Postoperative 
complications within 30 
days after surgery 
reported as mortality, 
morbidity, and admission 
to intensive care 
Smokers were at a higher 
risk for various 
postoperative complications 
including: general morbidity 
(Relative Risk (RR) 1.54; 
95% Confidence Interval 
(CI) 1.33-1.75), wound 
complications (RR 2.15; 
95% CI 1.87-2.49), general 
infection (RR 1.38; 95% CI 
Ambiguous 
definitions of smoking 
status, diverse time intervals 
(no sensitivity analysis by 
time), majority of studies 
included few participants or 
no confounder adjustment 
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1.32-1.79), pulmonary 
complications (RR 1.73; 
95% CI 1.35-2.23), 
neurological complications 
(RR 1.38; 95% CI 1.01-
1.88) and admission to 
intensive care (RR 1.60; 
95% CI 1.14-2.25) after an 
operation.  
Haddock, J., & Burrows, C. 
(1997). The role of the nurse in 
health promotion: an 
evaluation of a smoking 
cessation program in surgical 
pre-admission clinics. Journal 
of Advanced Nursing 26 (6), 
1098-110. 
To improve the health 
status of individuals 
admitted for surgery 
and prepare them for 
the no smoking policy. 
2 Quasi 
experimenta
l, quantities, 
randomized, 
convenience 
sample 
n = 60. 30 to 
control and 30 to 
treatment. 
Treatment 
received 
educational 
interventions 
and self 
assessment 
questionnaires 
treatment group- 
educational intervention, 
self-assessment, 
questionnaire, cessation 
aids, diary, 15 minute 
counseling. Control 
group: routine 
information or usual care 
stop or reduce smoking 
prior to hospital admission
80% of treatment group and 
50% of control group 
abstained from smoking or 
stopped before admission. 
no reliability or 
validity testing. 
Generalization of results. 
Small sample size. No 
control group. Uses 
subjective rather than 
empirical indicators. 
Kuri, M., Nakagawa, M., 
Tanaka, H., Seiko, H., & Kishi, 
Y. (2005). Determination of the 
duration of preoperative 
smoking cessation to improve 
wound healing after head and 
neck surgery. Anesthesiology 
102(5), 892-896. 
to assess the duration 
of preoperative 
smoking cessation that 
reduces the incidence 
of impaired wound 
healing in patients 
who undergo 
reconstructive head 
and neck surgery that 
would reduce the rate 
of postoperative 
complications. 
3 Retrospectiv
e cohort 
study: Non-
experimenta
l 
n=188 (Smokers 
n=28, Ex-
smokers n=120 
(smoke free 
between 8-21 
days n=34, 
between 22-
42days n=20 & 
>/= 43days 
n=66) & 
Nonsmokers 
n=40) 
None wound complications-
postoperative debridment, 
resuture, or reconstruction 
of their flap before 
hospital discharge. 
impaired wound healing 
began to decrease in pts 
who stopped smoking 1-4 
weeks before surgery.  
Further declining trends 
seen in 5-8wks. Longer than 
3 weeks preoperatively  
Older study. The 
definition of smoking status. 
Was not confirmed using 
biological techniques. 
Miscalculation could over 
estimate the risk of 
developing a postoperative 
pulmonary complication. 
Urges the development of an 
effective cessation program 
for outpatients to obtain the 
necessary length of cessation 
and to make primary care 
physicians aware of such 
programs. 
Lauerman, C.J. (2008). 
Surgical patient education 
related to smoking. AORN 
Journal, 87(3), 599-609.  
to determine what 
information is 
provided to education 
surgical patients who 
smoke about the 
effects of continued 
smoking on surgery 
outcomes 
3 Meta-
synthesis 
Nine studies None Addressed smoking 
education provided before 
surgical intervention 
Smoking cessation 
education for the surgical 
patient  is not consistent 
Small number of 
studies 
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Lindström, D., Sadr Azodi, O., 
Wladis, A., Tønnesen, H., 
Linder, S., Nåsell, H., & 
Adami, J. (2008). Effects of a 
perioperative smoking 
cessation intervention on 
postoperative complications: A 
randomized trial. Annals of 
Surgery, 248(5), 739-745. 
To determine whether 
smoking cessation 
intervention 4 weeks 
prior to surgery would 
reduce frequency of 
postoperative 
complications 
1 Randomized 
Control 
Trial 
patients having 
inguinal and 
umbilical hernia 
repair. Control: 
n=54, 
Intervention: 
n=48. Median 
age~55 
Individual smoking 
counseling and NRT 4 
weeks preoperatively and 
continued 4 weeks 
postoperatively 
Frequency of any 
postoperative 
complication. 
Complication rate in 
intervention group was 21% 
(p = 0.03) and control 41%. 
Abstainers had fewer 
complications (15%) than 
those who continued to 
smoke or only reduced 
smoking (35%)-Not 
statistically significant. >4 
weeks 
Frequency of patients 
who declined participation 
may effect external validity, 
small number of patients 
may increase the risk of type 
II error, smoking status, 
definition of postoperative 
complications and possible 
information bias. 
Mills, E., et al. (2011). Smoking 
cessation reduced 
postoperative complications: A 
systemic review and meta-
analysis. The American Journal 
of Medicine, 124(2), 144–154. 
To review RCT and 
observational evidence 
to establish the effect 
of preoperative 
smoking cessation on 
postoperative 
compilations and to 
determine if there is an 
optimal cessation 
period before surgery. 
1 Meta- 
analysis 
Review of 6 
RCT and 15 
observational 
studies 
evaluating the 
effect of 
smoking 
cessation on 
postoperative 
complications 
for past and 
current smokers. 
Smoking abstinence at a 
defined time point before 
surgery: Any 
classification of cessation 
postoperative 
complications, secondary 
outcomes (wound healing, 
cardiopulmonary 
complications, all cause 
mortality and all cause 
LOS) 
Each week of cessation 
result in a larger effect size. 
No optimal time given. >4 
weeks 
heterogeneous 
reporting of outcomes, 
inconsistent definitions of 
past smoking status, and 
differences in study designs 
across observational studies. 
Møller, A.M., Pedersen, T., 
Villebro, N., & Munksgaard, 
A. (2003). Effect of smoking on 
early complications after 
elective orthopedic surgery. 
The Journal of Bone and Joint 
Surgery. British Volume, 85(2), 
178-181. 
To study effects of 
smoking on the 
outcomes after 
elective orthopedic 
procedures 
3 Retrospectiv
e cohort 
study: Non-
experimenta
l 
n=811 (smokers: 
232 and non 
smokers: 579) 
mean age 
smokers: 68, 
non: 73. 14 
cigs/day, 35 
pack years 
None cardiac events ICU 
admits, wound healing, 
death, surgical revision, 
length of hospital stay 
the number of smokers with 
any postoperative 
complication was 
significantly (p = 0.02) 
higher than the number of 
nonsmokers. Wound 
complications prolonged 
hospital stays on average 
four days and any 
complication 3 days. 
Variance in age of 
smokers-were 5 years 
younger than the nonsmoker 
counterparts. Variation 
between subjects. 
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Moller, A.M., Villebro, N., 
Pedersen, T., & Tonnesen, H. 
(2002). Effect of preoperative 
smoking intervention on post-
operative complications: A 
randomized clinical trial. 
Lancet 359, 114-117.  
To determine effects 
of smoking cessation 
on postoperative 
complications 
1 Randomized 
Control 
Trial 
Intervention: 
n=56, mean 
age=66, pack 
years=35. 
Control: n=52, 
age=64, pack 
years=37. Hip or 
knee arthoplasty 
between Jan 
1999-Dec 2000 
Randomly assigned to 
Intervention: weekly 
meetings with study 
nurse, Nicotine 
replacement therapy, and 
counseling 6-8 weeks 
before surgery. Control: 
standard perioperative 
care with no active 
intervention program 
postoperative 
complications, death 
morbidity, 4 weeks after 
surgery, length of stay 
reduction of postoperative 
complications with 
intervention program 6-8 
weeks prior to surgery, most 
relevant decrease post op 
complication is wound 
related. The overall 
postoperative complication 
rate was 18% in the 
intervention group and 52% 
in the control group. 
Greatest benefit observed 
was in wound complications 
(hematoma, infection, 
subfascial involvement) 
with respective 5% and 31% 
in control group. Lower 
cardiovascular 
complications (MI and 
chronic heart failure) 0% vs. 
10% and secondary surgery 
4% vs. 15%. 6-8 weeks 
minimum. 3 weeks 
improvement in wounds. 
Non-randomized material 
and differences in baseline 
risk motivation for smoking 
cessation. Exact duration of 
smoking abstinence 
necessary to reduce 
complications cannot be 
concluded. 
Myers, K., Hajek, P., Hinds, 
C., McRobbie, H. (2011). 
Stopping smoking shortly 
before surgery and 
postoperative complications: A 
systemic review and meta-
analysis. Archives of Internal 
Medicine, 171(11), 983–989. 
To examine existing 
smoking studies and to 
compare surgical 
patients who have 
recently quit smoking 
with those who 
continue to smoke to 
provide an evidence 
based recommend- 
dation for staff. 
1 Systematic 
review with 
meta 
analysis 
889 patients in 9 
studies 
None effects (beneficial vs. 
detrimental) of quitting 
smoking 
combined studies show no 
benefit or detriments to 
quitting for less than 8 
weeks.  
Meta-analysis combined 
different types of surgical 
procedures and had various 
definitions of postoperative 
outcomes. 
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Nakagawa, M., Tanaka, H., 
Tsukuma, H., & Kishi, Y. 
(2001). Relationship between 
the duration of the 
preoperative smoke-free 
period and the incidence of 
postoperative pulmonary 
complications after pulmonary 
surgery. Chest, 120(3), 705. 
To examine the 
relationship between 
the duration of 
preoperative smoking 
free period and the 
development of postop 
pulmonary 
complications (PPC) 
in patients who 
underwent pulmonary 
surgery and to 
determine the optimal 
period of smoking 
cessation. 
3 Retrospectiv
e cohort 
study: Non-
experimenta
l 
288 consecutive 
patients who 
underwent 
pulmonary 
surgical 
procedure at 
institution from 
1997-1998. 
Current smokers 
(CS) (n=37): 
smoked within 2 
weeks of 
operation; 
Recent smokers 
(RS) (n=13): 
Smoke free 2-4 
weeks prior to 
surgery; Ex-
smokers (EX) 
(n=121): Smoke 
free for >4 
weeks; Never 
smoked (NS) 
(n=117) 
None atelectasis, pneumonia, 
PACo2 > 50mmhg, air 
leak/effusion, fistula, 
empyema, chylothorax, 
hemothorax, tension 
pneumothorax, pulmonary 
embolism, lobar gangrene, 
mechanical ventilation, 
intercostal tube drainage. 
Many PPC had time limits 
applied-see article for 
details. 
PPC: CS: 43.2%; RS: 
53.8%; ES: 34.7%; NS 
23.9%. 8 weeks cessation 
ES experienced similar PPC 
as NS. PPC incidence began 
to decrease with 5-8 weeks 
preoperative smoking 
cessation. 5 weeks 
minimum. 
nicotine use was self 
reported (not confirmed with 
CO or nicotine metabolite 
recording).  
Shannon-Cain, J., Webster, 
S.F., & Cain, B.S (2002). 
Prevalence of and reasons for 
preoperative tobacco use. 
AANA J, 70, 33–40. 
To determine why 
patients who smoke 
regularly will not 
abstain from tobacco 
use before surgery and 
describe patients 
perception of the 
reasons they did not 
abstain from tobacco 
use. 
3 Descriptive 
study, non-
experimenta
l, 
retrospectiv
e 
n= 81 scheduled 
for outpatient 
surgery. 
Researcher 
developed 
questionnaire on 
preoperative 
tobacco use 
None Smoking cessation 24 
hours before elective 
surgery. Variables 
measured were smoking 
history, tobacco addiction, 
and preoperative 
education. 
37 patients received no 
instruction to quit smoking 
preoperatively, 2 patients 
abstained from smoking on 
their own, 44 were 
counseled to abstain from 
smoking. Counseling 
resulted in a 5 time increase 
in cessation rates. 
Non randomized participant 
selection 
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Schmid, M., et al. (2015). 
Impact of smoking on 
perioperative outcomes after 
major surgery. The American 
Journal of Surgery, 210, 221-
229. 
To determine the 
impact of smoking on 
postoperative 
outcomes  
1 Meta-
analysis and 
systemic 
review 
141,802 patients 
undergoing one 
of the 16 major 
cardiovascular, 
orthopedic or 
oncologic 
surgical 
procedures were 
analyzed.  
 16 major cancer and 
noncancerous surgical 
procedures: 
"Cardiovascular surgery": 
carotid endarterectomy, 
coronary artery bypass 
grafting, lower extremity 
bypass surgery, abdominal 
aortic aneurysm repair, 
cardiac valve repair or 
replacement, "orthopedic 
surgery": total hip or knee 
replacement and 
"oncologic surgery": 
esophagectomy, 
gastrectomy, 
pancreatectomy, 
colectomy, radical 
prostatectomy, 
cystectomy, nephrectomy, 
hysterectomy, or 
pneumonectomy 
current smokers had higher 
odds of developing 
pulmonary, wound, and 
septic shock complications 
when compared to 
nonsmokers. 
Retrospectively, the risk of 
developing one 
complication was 12.5% in 
nonsmokers, 14.6% in 
former smokers and 14.9% 
in current smokers. 
Procedure dependent. 
Restricted by the lack of data 
on duration of smoking 
cessation, current smokers 
were identified as those who 
smoked within the last year 
so those patients who 
successfully discontinued 
smoking prior to surgery 
remained categorized as 
current smokers which may 
lead to an underestimated 
effect of smoking on 
postoperative complications, 
quantity of cigarettes 
smoked per day were not 
captured, and particulars of 
the surgical encounter. 
Sørensen, L.T., & Jørgensen, 
T. (2003). Short‐term 
pre‐operative smoking 
cessation intervention does not 
affect postoperative 
complications in colorectal 
surgery: A randomized clinical 
trial. Colorectal Disease, 5(4), 
347-352.  
To determine whether 
short term 
preoperative smoking 
cessation in colorectal 
surgery reduced 
incidence of wound 
complications 
1 Randomized 
Control 
Trial 
n=60 initially, 
57 at completion 
(27 intervention, 
30 control). 
Mean age 65, 
66, cigs/day: 
20,13 
Intervention: smoking 
cessation immediately 
following preoperative 
consult (2-3 weeks prior 
to colorectal surgery), 
nicotine replacement 
(patch, gum, spray), 
phone call from nurse 
after one day of 
cessation, one visit to 
clinic or patient's home. 
Control: typical pre op 
treatment, no consults, 
maintain typical smoking 
habits 
occurence of adverse 
events within 30 days of 
surgery (wound 
dehiscence, infection, 
necrosis, pulmonary 
complications, length of 
hospital stay) 
No significant difference 
between control and 
intervention for all variables 
measured (Fisher's Exact, 
Mann-Whitney U, P= 0.05). 
Recommended > 6weeks. 
No effect if cessation is < 
2weeks. 
intervention group was not 
nicotine free. Approximately 
half of the control group quit 
or reduced number of 
cigarettes per day following 
surgery, some intervention 
patients smoked even though 
they weren't supposed to 
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Sørensen, L.T. (2012). Wound 
healing and infection in 
surgery: The 
pathophysiological impact of 
smoking, smoking cessation, 
and nicotine replacement 
therapy: A systematic review. 
Annals of surgery, 255(6), 1069. 
To clarify how 
smoking and nicotine 
affect wound healing 
processes and to 
establish if smoking 
cessation and nicotine 
replacement therapy 
reverse mechanisms 
involved 
1 Meta-
analysis 
177 articles None Wound healing Smoking cessation restores 
the tissue microenvironment 
rapidly and the 
inflammatory cellular 
functions within 4 weeks 
This article was mainly 
concerned with the 
examination of the 
physiology effects of 
smoking on the body, and at 
the cellular level. Mention is 
made of the lengths of 
cessation for certain 
processes to return to 
normal. Several of these 
changes occur at the 4 week 
cessation mark, hinting at an 
optimal minimum time for 
smoking cessation 
preoperative. 
Sørensen, L.T. (2012). Wound 
healing and infection in 
surgery: The clinical impact of 
smoking cessation: A systemic 
review and meta-analysis. Arch 
surgery, 147(4), 373–383. 
To clarify the 
evidence on smoking 
and postoperative 
healing complications 
across surgical 
specialties and to 
determine the impact 
of perioperative 
smoking cessation 
intervention. 
2 Systematic 
review with 
meta 
analysis 
Smokers and 
nonsmokers 
were compared 
in 140 cohort 
studies including 
479,150 patients 
and 4 RCT 
including 477 
patients 
 All types of adverse 
healing events: skin 
incision, short-term 
healing outcomes (wound 
and tissue flap necrosis, 
healing delay, dehiscence 
of wounds and sutured 
tissue, surgical site 
infections, non-specified 
wound complications) and 
long term-healing 
outcomes (hernia and lack 
of fistula or bone healing) 
Postoperative healing 
complications occur 
significantly more often in 
smokers compared with 
nonsmokers and in former 
smokers compared with 
those who never smoked. 
See study for specifics. 
Smoking cessation >4 
weeks before surgery to 
reduce surgical site 
infections. 
Possible error and bias 
during review process and 
poor quality of cohort 
studies. 
Sørensen, L. T., Hemmingsen, 
U., & Jørgensen, T. (2007). 
Strategies of smoking cessation 
intervention before hernia 
surgery—effect on 
perioperative smoking 
behavior. Hernia, 11(4), 327-
333.  
To study the effect on 
perioperative smoking 
behavior and on 
postoperative wound 
infection of different 
types of low intensive 
intervention before 
herniotomy 
2  Experiment
al pretest-
posttest with 
quasi 
experimenta
l after only 
component 
n=180 smokers, 
15-20 cigs/day,  
mean age 54-56. 
Preoperative for 
hernia repair 
surgery in 
Denmark. 
Smoking cessation: 
standard advice to stop 
smoking preoperative 
(n=48), standard plus 
telephone intervention, 
standard plus nurse visit 
intervention. For data 
analysis, both 
intervention groups were 
combined (n=101) A 
fourth group of smokers 
who received no advice 
to quit smoking (n=64) 
were added 
retrospectively (chart 
audit). 
Nicotine test and CO 
breath test initial 
appointment, day of 
surgery day of suture 
removal; Fagerstrom 
nicotine dependence 
score. LASA motivation 
score, % who stopped,  % 
maintained abstinence, 
appearance of wound at 
suture removal. 
preoperative 19% of advised 
cohort had stopped smoking 
vs. 2% in non-advised 
cohort. (No significant 
difference between 
reminder group and 
standard group). Reminded 
pts reduced median 
cigarettes, while standard 
and non-advised did not 
change. CO for reminder 
groups were lower than for 
standard group. NSD in  
post op infections between 
groups. 
highly intensive smoking 
cessation interventions is 
necessary to achieve high 
cessation rate for long 
preoperative period (3 
months in this study), CO 
level was a better predictor 
of cessation than Fagerstrom 
score. Low intensity 
intervention had no effect on 
postop wound infection (due 
to insufficient sample size). 
Simple prop advice helped 
~20% of patients to stop 
smoking. 
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Theadom, A., & Cropley, M. 
(2006). Effects of preoperative 
smoking cessation on the 
incidence and risk of 
intraoperative and 
postoperative complications in 
adult smokers: A systematic 
review. Tobacco Control, 15(5), 
352-358 
To establish the effect 
of preoperative 
smoking cessation on 
the risk of 
postoperative 
complications and to 
identify the effect of 
the timing of 
preoperative cessation 
3 Prospective 
cohort 
studies: 
Non-
experimen 
tal 
12 research 
articles reviewed 
current smokers 
(CS), past 
smokers (PS), 
and nonsmokers 
(NS).  
None % of patients experiencing 
postoperative 
complications (general 
pulmonary, coughing, 
respiratory infections, 
wound infection), sputum 
volume, amount of 
anesthesia required, 
mortality. Complication is 
defined as a secondary 
disease or a negative 
reaction during the course 
of or after surgery 
studies revealed: higher 
complications in pts who 
stopped smoking more than 
4w before breast recon 
surgery, compared to 
nonsmokers; pts who 
stopped smoking within 2 
months of surgery had an 
increase risk of 
complications when 
compared to pts who 
stopped more than 2 months 
preoperative; pts who 
stopped smoking for more 
than 6 months preoperative 
had reduced mortality; pts 
who stopped smoking less 
than four weeks before 
surgery had lower incidence 
of all pulmonary 
complications than CS; pts. 
who quit one month before 
surgery had same 
pneumonia rate as NS 
Definition of postoperative 
complication, smoking 
status, differences in 
characteristics of sample and 
surgical procedure 
performed, publication bias. 
Generally, CS had a higher 
rate of postop complications 
than NS. Only one study 
found a significant increase 
in postop complications 
from short term preoperative 
smoking cessation. It 
appears that patients who 
quit even short term reduce 
their risk of complications 
compared to CS.  
Thomsen, T., Tonnesen, H., & 
Moller, A.M. (2009). Effect of 
preoperative smoking 
cessation interventions on 
postoperative complications 
and smoking cessation. British 
Journal of Surgery, 96, 451–
461. 
To examine the effect 
of preoperative 
smoking cessation 
interventions on 
postoperative 
complications and 
smoking cessation 
short and long term 
1 Systematic 
Review 
Eleven RCTs 
with 1194 
patients 
Smoking cessation 
interventions of 
intensive, medium 
intensity and less 
intensive. Could include 
5 a's, behavioral 
counseling tailored at 
stage of change, 
motivational 
interviewing, or other 
methods (person-person 
phone, groups or 
computer) 
Postoperative 
complications 30 days 
after surgery. Wound 
healing complications, 
respiratory, cardiovascular 
and urological 
complications and other 
complications requiring 
treatment. 
Intensive interventions 
increased smoking cessation 
rates preoperatively (pooled 
risk ration 0.56 and 
12months thereafter. 
Medium intensity to less 
intensive interventions were 
not significant for long-term 
smoking cessation or 
significant reductions in 
postoperative 
complications, Cessation at 
least 4 weeks 
preoperatively. 
variation between samples 
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Thomsen, T., Tonnesen, H., 
Okholm, M., Kroman, N., 
Maibom, A., Sauerberg, M., & 
Moller, A. (2010). Brief 
smoking cessation intervention 
in relation to breast cancer 
surgery: A randomized 
controlled trial. Nicotine 
Tobacco Research, 12(11), 
1118-24. doi: 
10.1093/ntr/ntq158 
Examine if a brief 
smoking cessation 
intervention shortly 
before breast cancer 
surgery would 
influence 
postoperative 
complications and 
smoking cessation 
1 Randomized 
Control 
Trial with 
Blinded 
Outcome 
130 patients 
were randomly 
assigned to brief 
smoking 
intervention 
(n=65) or 
standard care 
(n=65) 
Followed principles of 
motivational 
interviewing and 
included personalized 
nicotine replacement 
therapy, aimed at 
supporting cessation 2 
days before to 10 days 
after surgery. 
Overall complication 
rates; defined as death or 
postoperative morbidity 
requiring treatment within 
30 days after surgery, 
including seroma with 
aspiration. Length of 
hospital stay, need for 
secondary surgery and 
readmission within 30 
days due to complication 
to primary surgery 
Overall postoperative 
complication rate was 61% 
in both groups, risk ratio 
(RR) 1.00 (95% CI 0.75-
1.33). Wound complications 
44% versus 45%. 
Perioperative smoking 
cessation, 28% intervention 
versus 11% control. No 
effect on smoking cessation 
at 12months, 13% versus 
9%.  
Strength: allocation 
concealment was secure and 
blinded outcomes 
assessment. Limits: 
Classification of 
postoperative complications, 
small sample size, self report 
of smoking cessation, 
potential contamination of 
effect of intervention (not 
biochemically validated), 
potential reveal of group 
allocation over time 
(decrease in internal 
validity) and generalization 
to other cancer patients, 
gender or surgical 
procedures. 
Thomsen, T., Villebro, N., & 
Møller, A.M. (2014). 
Interventions for preoperative 
smoking cessation. Cochrane 
Database Syst Rev, 27(3), doi: 
10.1002/14651858.CD002294.p
ub4. 
The objectives of this 
review are to assess 
the effect of 
preoperative smoking 
intervention on 
smoking cessation at 
the time of surgery 
and 12 months 
postoperatively, and 
on the incidence of 
postoperative 
complications. 
1 Meta-
analysis 
Randomized 
controlled trials 
that recruited 
people who 
smoked prior to 
surgery, offered 
a smoking 
cessation 
intervention, and 
measured 
preoperative and 
long-term 
abstinence from 
smoking or the 
incidence of 
postoperative 
complications or 
both outcomes. 
None Smoking cessation at the 
time of surgery and 12 
months afterwards. 
Morbidity and mortality: 
wound complications, 
secondary surgery, 
cardiopulmonary 
complications, admission 
to intensive care, intra and 
postoperative mortality, 
length of stay. 
preoperative smoking 
interventions providing 
behavioral support and 
offering Nicotine 
replacement therapy 
increase short-term smoking 
cessation and may reduce 
postoperative morbidity. he 
optimal preoperative 
intervention intensity 
remains unknown. Based on 
indirect comparisons and 
evidence from two small 
trials, interventions that 
begin four to eight weeks 
before surgery, include 
weekly counseling and use 
Nicotine replacement 
therapy are more likely to 
have an impact on 
complications and on long-
term smoking cessation.         
4 weeks minimum 
Differences between studies 
definitions of postoperative 
complications and smoking 
cessation, specifically 
smoking at the time of 
surgery could be sources 
effecting the heterogeneity 
of the strength of 
conclusions drawn. Attitudes 
around smoking cessation 
may have changed in more 
recent studies used in this 
analysis. 
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Tønnesen, H., Faurschou, P., 
Ralov, H., Mølgaard-Nielsen, 
D., Thomas, G., & Backer, V. 
(2010). Risk reduction before 
surgery: The role of the 
primary care provider in 
preoperative smoking and 
alcohol cessation. BMC Health 
Services Research, 10(1), 121-
121. 
To evaluate integrated 
clinical practice for 
smokers and drinkers 
admitted for elective 
surgery, focusing on 
GP referral to smoking 
cessation program 
2 Quasi 
experimenta
l, before and 
after 
intervention 
n=72 high risk 
(daily smokers, 
drinkers >14 
drinks/week for 
women, >21 for 
men) 
instruction of general 
providers to refer patients 
to smoking cessation 
program preoperatively. 
Identification of barriers 
to patients and general 
providers. Attempt at 
minimizing and 
removing barriers during 
study. Duration: 9 
months 
number of patients 
referred by general 
providers to smoking 
cessation program 
concurrent with referral to 
elective surgery 
7/72 were referred to 
program by 11 different 
general providers (poor 
referral rate). This was an 
increase of 10%. 4-8 weeks 
Effect of the study was 
limited to the participation of 
the general provider and 
hospital surgical 
departments. 
Turan, A., Mascha, EJ., 
Roberman, D, et al. (2011). 
Smoking and perioperative 
outcomes. Anesthesiology, 114, 
837-846. 
The effects of 
smoking on outcomes 
30 days after major 
surgery were 
evaluated  
3 Retrospectiv
e cohort 
study-Non-
experimenta
l 
520,242 non-
cardiac surgical 
patients from the 
college of 
surgeons 
national surgical 
quality 
improvement 
program 
database 
None Classified based on major 
morbidity (30d mortality, 
surgical site infection, 
Pneumonia, unplanned 
intubation, PE, vent >48h, 
stroke/CVA, coma >24h, 
cardiac arrest, MI, 
bleeding/transfusions, 
sepsis and septic shock). 
And minor morbidity 
(superficial site infection, 
deep incisional infection, 
wound disruption, renal 
insufficiency, UTI, DVT 
Smokers experienced 
significantly greater odds of 
adverse events 
postoperatively including: 
higher rates of pneumonia, 
unplanned intubation, 
myocardial infarction, 
stroke, superficial and deep 
incisional infections and 
sepsis.  
Small sturdies focusing on 
specific results, smoking 
status in weeks or days was 
not recorded, missing values 
in the ACS-NSQIP, unable 
to adjust for each type of 
hospital, and study includes 
heterogeneous set of surgical 
procedures 
Warner, D.O. (2005). 
Preoperative smoking 
cessation: the role of primary 
care provider. Mayo Clinic 
Proceedings, 80(2), 252-258. 
Review examines why 
it is important for 
surgical patients to 
abstain from tobacco 
in the perioperative 
period and how 
primary providers can 
help them do so. 
4 Systematic 
reviews of 
descriptive 
studies 
None None None Perioperative period is a 
unique time to intervene 
with smoking cessation 
messages. Teachable 
moment. 
This is a "review" for 
primary providers. A critical 
appraisal of the evidence? 
Wolfenden, L., Wiggers, J., 
Knight, K., Campbell, E., 
Spigelman, A., Kerridge, R., & 
Moore, K. (2005). Increasing 
smoking cessation care in the 
preoperative clinic: A 
randomized controlled trial. 
Preventative Medicine, 41(1), 
264-290. 
To assess the 
efficiency, 
acceptability and cost 
of a comprehensive 
smoking cessation 
care program in 
preoperative clinics 
and to facilitate the 
provision of patients 
attending the smoking 
cessation care program 
1 Experiment
al- Random 
n= 81 treatment 
group/n=62 
control group 
Computerized smoking 
assessment program, 
printed materials, tailored 
self-help material 
smoking cessation at least 
24 hours before surgery 
73% in treatment group/ 
53% in control group. 50% 
of the experimental group 
and 13% of usual care group 
received all appropriate 
elements of care. 40% of 
experimental group did not 
receive cessation advice 
from anesthesiologist 
no reliability or validity 
testing 
PREOPERATIVE SMOKING CESSATION                       44 
Wong, J., Lam, D.P., 
Abrishami, A., Chan, M.T.V., 
& Chung, F. (2012). Short-
term preoperative smoking 
cessation and postoperative 
complications: A systematic 
review and meta-analysis. 
Canadian Journal of 
Anesthesia/Journal Canadien 
d'Anesthésie, 59, 268-279. 
To determine the risks 
or benefits of short-
term smoking 
cessation on 
postoperative 
complications and to 
derive the minimum 
duration of 
preoperative 
abstinence from 
smoking required to 
reduce such 
complications in adult 
surgical patients 
2 Meta-
analysis 
review of 25 
selected cohort 
studies and 
RCTs that 
examined post 
operative 
complications of 
patients who quit 
smoking within 
6 months of 
surgery 
compared to 
those in current 
smokers 
None respiratory, 
cardiovascular, and 
wound healing 
complications 
Respiratory: abstinence 
>8w: risk same as NS; 4-8w 
lower than CS, 2w & 2-4w 
NSD from CS. CV: NSD 
between NS, CS and ex 
smokers. Wound: 2x risk in 
CS vs. NS, <3-4w had 
greater risk than NS, >3-4w 
NSD to NS. Bottom line: 
cessation >4w before 
surgery reduced respiratory 
complications by 23%, >8w 
by 47% (comparable with 
NS). Abstinence >3-4w had 
fewer wound complications 
than CS. Quit >4 weeks less 
pulmonary and wound 
complications. <4 weeks, no 
effect. 
Limitations: few studies had 
high methodological quality, 
most studies were 
retrospective observational. 
Many studies did not adjust 
for confounding factors 
between groups. Most 
studies relied on self 
reporting of smoking status. 
Smoking cessation intervals 
in some studies were not 
clearly defined, intervals 
overlapped. 
Zaman, M., Bilal, H., 
Mahmood, S., & Tang, A. 
(2012). Does getting smokers to 
stop smoking before lung 
resections reduce their risk? 
Interactive Cardiovascular and 
Thoracic Surgery, 14(3), 320-
323.  
To determine whether 
the incidence of major 
pulmonary morbidity 
after lung resection is 
associated with timing 
of smoking cessation 
3 Meta-
synthesis 
49 papers were 
found (Medline 
search 1950-
2011 using 
OVID:  
None examined overall 
pulmonary complications 
for patients quitting or not 
quitting at various 
intervals before surgery 
Smoking cessation reduces 
risk of pulmonary 
complications, however an 
optimal interval of cessation 
is not clear. Evidence 
indicates that risk declines 
with longer smoke free 
period. Patients should be 
counseled to quit smoking 
prior to surgery, regardless 
of the time period. No 
optimal time defined. 
Study selection bias 
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Appendix B 
Strength-of Evidence 
Classification 
Criteria 
Strength of Evidence = A There is good evidence to support the recommendation. 
 Multiple well-designed randomized clinical trials, directly 
relevant to the recommendation, yielded a consistent pattern of 
findings. 	
 
Strength of Evidence = B There is fair evidence to support the recommendation. 
 Some evidence from randomized clinical trials supported the 
recommendation, but the scientific support was not optimal. 
For instance, few randomized trials existed, the trials that did 
exist were somewhat inconsistent, or the trials were not 
directly relevant to the recommendation. 	
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Strength of Evidence = C There is poor evidence regarding the inclusion or exclusion 
of the recommendation but recommendations may be made on 
other grounds. 
 Reserved for important clinical situations in which the Panel 
achieved consensus on the recommendation in the absence of 
relevant randomized controlled trials.	
 
Adapted from the U.S Department of Health and Human Services, Public Health Service. 
Treating Tobacco Use and Dependence. 2008 Update. Clinical Practice Guideline, 2008. p. 77.  
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Appendix C 
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Smoking harms nearly every organ in the body. When compared to nonsmokers, 
smokers can experience: 
 Longer hospitalizations 
 Delays in discharge 
 Transfer to more intensive levels of care  
 Increases in healthcare costs 
 Additional surgical or medical intervention 
 
Pathological changes are fully or at least partially reversible with preoperative 
smoking cessation: 
 Smoking cessation gradually improves pulmonary function, and becomes similar 
to that of nonsmokers after a cessation period of four to eight weeks with longer 
periods of cessation reducing risk. 
 Of the 7,000 chemicals compounds found in cigarettes, 4,000 can adversely 
affect wound healing. Significant reductions in surgical site infection and 
impaired wound healing are demonstrated with three to eight weeks of smoking 
cessation. 
Quit Line: 
 Call for FREE help: 1-800- QUIT- NOW (1-800-784-8669) 
 Text QUIT to 47848, answer a few questions, and you'll start receiving messages 
 
 Pneumonia 
 Sepsis 
 Stroke 
 Unplanned intubation 
 Increases in mortality 
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